Xavier Morato

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

When treatment becomes risk: polypharmacy and inappropriate prescribing in cognitive impairment in 2379 consecutive patients from a memory clinic.

When treatment becomes risk: polypharmacy and inappropriate prescribing in cognitive impairment in 2379 consecutive patients from a memory clinic.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 26, 2026

Comparative proteomic analysis of cerebrospinal fluid and brain tissue using Orbitrap Astral and timsTOF Pro 2 platforms with data-independent acquisition.

Comparative proteomic analysis of cerebrospinal fluid and brain tissue using Orbitrap Astral and timsTOF Pro 2 platforms with data-independent acquisition.

Journal: Diagnosis (Berlin, Germany)
Published: December 17, 2025

Validation of human kallikrein 6 in the cerebrospinal fluid of patients with progressive and non-progressive alzheimer's disease: correlation with other biomarkers.

Validation of human kallikrein 6 in the cerebrospinal fluid of patients with progressive and non-progressive alzheimer's disease: correlation with other biomarkers.

Journal: Clinical proteomics
Published: September 26, 2025

A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

Journal: Nature medicine
Published: May 29, 2025

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease.

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 08, 2025

Author Correction: Systematic protein-protein interaction mapping for clinically relevant human GPCRs.

Author Correction: Systematic protein-protein interaction mapping for clinically relevant human GPCRs.

Journal: Molecular systems biology
Published: January 06, 2025

Drug screening targeting TREM2-TYROBP transmembrane binding.

Drug screening targeting TREM2-TYROBP transmembrane binding.

Journal: Molecular medicine (Cambridge, Mass.)
Published: December 11, 2024

Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease.

Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD
Published: November 06, 2024

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD
Published: October 18, 2024

Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.

Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.

Journal: Brain, behavior, & immunity - health
Published: May 03, 2024

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic.

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic.

Journal: EBioMedicine
Published: December 22, 2023

Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique.

Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique.

Journal: Alzheimer disease and associated disorders
Published: December 05, 2023
Showing 1-12 of 38

Last Updated: 09/26/2026